A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice

作者：Fu, Ming; Lin, Zefeng; Lin, Huiting; Tong, Yanlu; Wang, Hezhen; Chen, Hongjiao; Chen, Yan; Zhang, Ruizhong^*

来源：Jove-Journal of Visualized Experiments, 2018, (140): e58158.

DOI：10.3791/58158

• Immunology and Infection
• Issue 140
• Biliary atresia
• silver nanoparticle
• rhesus rotavirus
• neonatal mouse
• intraperitoneal injection
• treatment

Biliary atresia (BA) is a severe type of cholangitis with high mortality in children of which the etiology is still not fully understood. Viral infections may be one possible cause. The typical animal model used for studying BA is established by inoculating a neonatal mouse with a rhesus rotavirus. Silver nanoparticles have been shown to exert antibacterial and antiviral effects; their function in the BA mouse model is evaluated in this study. Currently, in BA animal experiments, the methods used to improve the symptoms of BA mice are generally symptomatic treatments given via food or other drugs. The aim of this study is to demonstrate a new method for ameliorating BA syndrome in mice by the intraperitoneal injection of silver nanoparticles and to provide detailed methods for preparing the silver nanoparticle gel formulation. This method is simple and widely applicable and can be used to research the mechanism of BA, as well as in clinical treatments. Based on the BA mouse model, when the mice exhibit jaundice, the prepared silver nanoparticle gel is injected intraperitoneally to the surface of the lower liver. The survival status is observed, and biochemical indicators and liver histopathology are examined. This method allows a more intuitive understanding of both the establishment of the BA model and novel BA treatments.

• 出版日期2018-10
• 单位广州市妇女儿童医疗中心; 暨南大学; 广州医科大学